Results 201 to 210 of about 62,474 (297)

Real-Life Treatment Intervals and Morphological Outcomes Following the Switch to Faricimab Therapy in Neovascular Age-Related Macular Degeneration. [PDF]

J Pers Med
Löw K, Sitnilska V, Tang Y, Lammert JQ, Krohne TU, Altay L.   +5 more
europepmc   +1 more source

One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study [PDF]

, 2011
Lars Hjelmqvist, Charlotte Lindberg, Pär Kanulf, Henrik Dahlgren, Ingrid Johansson, Annica Siewert   +5 more
openalex   +1 more source

Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration. [PDF]

Br J Ophthalmol
Zur D, Guymer R, Korobelnik JF, Wu L, Viola F, Eter N, Baillif S, Chen Y, Arnold JJ.   +8 more
europepmc   +1 more source

Macular atrophy in neovascular age related macular degeneration

Advances in Ophthalmology & Visual System, 2019
Emad Selim, Marah Selim
openaire   +1 more source

Draft a protocol for an observational study for anti-VEGF therapy in age related macular degeneration [PDF]

, 2015
Μακρή, Όλγα
core   +1 more source

Inter-Relationships Between the Deep Learning-Based Pachychoroid Index and Clinical Features Associated with Neovascular Age-Related Macular Degeneration. [PDF]

J Clin Med
Saito M, Mitamura M, Ito Y, Endo H, Katsuta S, Ishida S.   +5 more
europepmc   +1 more source

Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration

, 2009
Ciro Costagliola, Mary Romano, Michele Rinaldi, Roberto dell’Omo, Flavia Chiosi, M. Menzione, Francesco Semeraro   +6 more
openalex   +2 more sources

Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany [PDF]

, 2012
Robert P. Finger, Peter Wiedemann, Francisca Blumhagen, Karin Pohl, Frank G. Holz   +4 more
openalex   +1 more source

Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study [PDF]

, 2012
Anne-Catherine Söderberg, Peep V. Algvere, Jan G. Hengstler, Pär Söderberg, Stefan Seregard, Anders Kvanta   +5 more
openalex   +1 more source

Real-World Evidence for Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Scoping Review. [PDF]

Ophthalmol Sci
Chaudhary V, Guymer R, Artignan A, Downey A, Singh RP.   +4 more
europepmc   +1 more source